Why life sciences companies are falling out of the innovation big leagues
Increased R&D outsourcing and patent licensing account for pharma’s diminishing representation among the world’s top 100 innovators, while technological diversification may also be playing its part
To read more
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the IAM experts.